Nelnet Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Nelnet Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income attributable to nelnet, inc. | 181,458,000 | 82,560,000 | 63,159,000 | 2,388,000 | 45,288,000 | 73,210,000 | -8,554,000 | 45,332,000 | 28,267,000 | 26,487,000 | 30,774,000 | 104,797,000 | 85,129,000 | 186,647,000 | 132,683,000 | 53,138,000 | 83,867,000 | 123,598,000 | 234,991,000 | 71,502,000 | 86,482,000 | -40,532,000 | 42,380,000 | 33,213,000 | 24,619,000 | 41,591,000 | 113,925,000 | 56,634,000 | 36,828,000 | 41,394,000 | 43,141,000 | ||||||||||||||||
net income attributable to noncontrolling interests | -3,605,000 | -1,430,000 | 268,000 | -4,329,000 | -1,867,000 | -2,202,000 | -21,359,000 | -3,096,000 | -9,172,000 | -3,470,000 | -2,791,000 | -4,328,000 | -2,226,000 | -1,761,000 | -3,536,000 | -1,919,000 | -854,000 | -694,000 | -3,385,000 | -327,000 | 128,000 | 767,000 | -547,000 | -77,000 | 59,000 | 56,000 | -740,000 | ||||||||||||||||||||
net income | 177,853,000 | 81,130,000 | 63,427,000 | -1,941,000 | 43,421,000 | 71,008,000 | -29,913,000 | 42,236,000 | 19,095,000 | 23,017,000 | 27,983,000 | 100,469,000 | 82,903,000 | 184,886,000 | 129,147,000 | 51,219,000 | 83,013,000 | 122,904,000 | 231,606,000 | 71,175,000 | 86,610,000 | -39,765,000 | 41,833,000 | 33,136,000 | 24,678,000 | 41,647,000 | 113,185,000 | 56,653,000 | 36,952,000 | 41,530,000 | 43,293,000 | 64,879,000 | 47,451,000 | 37,125,000 | 54,880,000 | 49,993,000 | 54,322,000 | 59,063,000 | 46,404,000 | 8,203,000 | 25,455,000 | 30,997,000 | 23,785,000 | 43,705,000 | -69,825,000 | ||
adjustments to reconcile net income to net cash from operating activities, net of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including debt discounts and loan premiums and deferred origination costs | 29,283,000 | 23,123,000 | 26,505,000 | 36,399,000 | 35,666,000 | 33,957,000 | 16,735,000 | 35,085,000 | 59,362,000 | 34,211,000 | 62,593,000 | 39,575,000 | 37,745,000 | 36,335,000 | 18,674,000 | 36,897,000 | 38,339,000 | 38,415,000 | 49,298,000 | 49,893,000 | 50,519,000 | 48,763,000 | 50,143,000 | 48,398,000 | 47,173,000 | 46,948,000 | 43,301,000 | ||||||||||||||||||||
loan discount and deferred lender fees accretion | -23,095,000 | -19,407,000 | -17,215,000 | -14,300,000 | |||||||||||||||||||||||||||||||||||||||||||
benefit from loan losses | 17,930,000 | 15,337,000 | 22,056,000 | 18,111,000 | 3,512,000 | 10,928,000 | 10,659,000 | -10,116,000 | -5,821,000 | 2,998,000 | 76,299,000 | 13,000,000 | 10,000,000 | 9,000,000 | 7,000,000 | 4,000,000 | 3,500,000 | 5,000,000 | 7,000,000 | 6,000,000 | 7,000,000 | 5,250,000 | 5,250,000 | 3,750,000 | 6,000,000 | 5,500,000 | 6,200,000 | 5,000,000 | 6,000,000 | 7,500,000 | 8,000,000 | 7,500,000 | 7,000,000 | 7,000,000 | 6,000,000 | 5,000,000 | |||||||||||
derivative market value adjustments | 3,866,000 | 6,324,000 | -13,792,000 | 13,165,000 | -1,533,000 | -7,964,000 | 9,507,000 | -3,141,000 | -2,004,000 | 37,411,000 | 7,434,000 | -52,990,000 | -40,401,000 | -145,734,000 | -48,358,000 | -7,261,000 | 1,615,000 | -38,809,000 | 7,072,000 | -3,441,000 | 3,911,000 | 20,602,000 | 2,930,000 | 5,630,000 | 37,061,000 | 30,574,000 | |||||||||||||||||||||
(payments to) proceeds from clearinghouse - initial and variation margin | -3,220,000 | -810,000 | -3,755,000 | -282,000 | 398,000 | -210,284,000 | -10,718,000 | 17,262,000 | -63,255,000 | -13,974,000 | |||||||||||||||||||||||||||||||||||||
gain on partial redemption of allo investment | |||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of loans | 0 | -909,000 | |||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on investments | -11,343,000 | -8,307,000 | |||||||||||||||||||||||||||||||||||||||||||||
deferred income tax benefit | -17,893,000 | -2,580,000 | -2,234,000 | 3,787,000 | 11,238,000 | -26,000,000 | -8,658,000 | 11,597,000 | -3,790,000 | 14,511,000 | 258,000 | 3,152,000 | -27,389,000 | ||||||||||||||||||||||||||||||||||
non-cash compensation expense | 3,398,000 | 3,115,000 | 3,091,000 | 2,950,000 | 2,838,000 | 3,166,000 | 4,495,000 | 4,171,000 | 3,972,000 | 3,838,000 | 4,304,000 | 3,701,000 | 3,251,000 | 2,920,000 | 2,849,000 | 2,844,000 | 2,928,000 | 2,052,000 | 11,201,000 | 1,957,000 | 1,724,000 | 1,857,000 | 1,833,000 | 1,810,000 | 1,662,000 | 1,476,000 | 1,161,000 | 854,000 | 754,000 | 712,000 | 700,000 | 455,000 | 482,000 | 535,000 | 557,000 | 561,000 | 600,000 | 596,000 | 523,000 | 1,650,000 | 1,298,000 | 1,273,000 | 3,099,000 | ||||
impairment expense and benefit from beneficial interests | 10,288,000 | 1,591,000 | 5,764,000 | 29,052,000 | |||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||
decrease in loan and investment accrued interest receivable | 1,730,000 | 13,488,000 | 79,841,000 | 16,630,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease in accounts receivable | 2,436,000 | 30,087,000 | 6,224,000 | -25,165,000 | 61,494,000 | 5,596,000 | 15,467,000 | 43,675,000 | 1,332,000 | ||||||||||||||||||||||||||||||||||||||
decrease in other assets | 3,140,000 | 27,094,000 | 5,147,000 | -8,000 | 66,000 | 1,124,000 | 1,140,000 | 10,433,000 | -12,013,000 | -60,000 | 4,509,000 | ||||||||||||||||||||||||||||||||||||
decrease in the carrying amount of rou asset | 1,004,000 | 954,000 | 1,007,000 | 946,000 | 958,000 | 953,000 | 1,022,000 | 1,469,000 | 1,139,000 | 1,251,000 | 1,226,000 | 1,741,000 | 1,296,000 | 1,439,000 | 1,518,000 | 1,690,000 | 2,444,000 | 3,202,000 | |||||||||||||||||||||||||||||
decrease in accrued interest payable | -3,098,000 | -2,974,000 | -4,842,000 | -3,408,000 | 125,000 | -481,000 | -605,000 | -23,174,000 | -3,148,000 | -1,866,000 | -1,551,000 | -1,094,000 | -353,000 | -3,566,000 | -574,000 | -3,017,000 | -10,052,000 | -13,165,000 | -33,500,000 | -6,244,000 | -36,706,000 | ||||||||||||||||||||||||||
increase in other liabilities | 38,791,000 | 66,405,000 | 34,613,000 | -11,265,000 | 3,174,000 | -15,601,000 | -36,205,000 | 1,408,000 | 14,040,000 | -9,622,000 | -11,637,000 | 7,338,000 | 7,437,000 | -4,625,000 | 1,319,000 | -31,898,000 | 23,959,000 | 7,799,000 | 2,817,000 | -15,816,000 | 26,586,000 | ||||||||||||||||||||||||||
decrease in the carrying amount of lease liability | -2,487,000 | -897,000 | -939,000 | -886,000 | -957,000 | -1,025,000 | -1,444,000 | -1,340,000 | -1,293,000 | -1,275,000 | -1,415,000 | -1,367,000 | -1,360,000 | -1,500,000 | -1,820,000 | -1,870,000 | -2,041,000 | -1,247,000 | -917,000 | -3,655,000 | -2,447,000 | -2,382,000 | |||||||||||||||||||||||||
other | 15,000 | 996,000 | -116,000 | -329,000 | -36,000 | -110,000 | -2,506,000 | 73,000 | -194,000 | -20,000 | -4,302,000 | ||||||||||||||||||||||||||||||||||||
total adjustments | -96,093,000 | 10,039,000 | |||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 81,760,000 | 91,169,000 | 180,533,000 | 137,038,000 | 133,404,000 | 211,915,000 | 79,761,000 | 154,235,000 | 76,134,000 | 122,845,000 | 27,187,000 | 173,158,000 | 298,249,000 | 185,465,000 | 155,174,000 | 202,082,000 | 138,953,000 | 48,658,000 | 39,780,000 | 278,636,000 | 38,854,000 | -144,455,000 | 155,997,000 | 160,753,000 | 121,830,000 | -139,665,000 | 57,952,000 | 38,721,000 | 99,330,000 | 60,696,000 | 100,571,000 | 98,916,000 | 43,730,000 | 86,549,000 | 81,667,000 | 179,038,000 | -45,581,000 | 58,725,000 | 2,686,000 | 110,056,000 | 58,634,000 | 45,650,000 | 110,366,000 | 63,526,000 | 70,480,000 | 112,154,000 | 74,943,000 |
capex | -3,696,000 | -3,378,000 | 17,377,000 | -4,438,000 | -10,617,000 | -23,225,000 | -21,448,000 | -15,351,000 | -12,823,000 | -24,430,000 | -14,998,000 | -10,271,000 | -18,358,000 | -15,794,000 | -16,358,000 | -13,810,000 | -10,886,000 | -17,898,000 | -32,614,000 | -33,704,000 | -21,433,000 | -25,561,000 | -24,818,000 | -23,966,000 | -18,902,000 | -24,813,000 | -28,068,000 | -2,574,000 | -2,965,000 | -2,099,000 | -2,306,000 | -4,391,000 | -1,495,000 | -5,289,000 | -2,992,000 | -5,274,000 | -2,826,000 | -1,787,000 | -2,883,000 | -738,000 | -22,000 | -382,000 | -62,000 | -47,000 | -1,373,000 | -2,371,000 | -1,350,000 |
free cash flows | 78,064,000 | 87,791,000 | 197,910,000 | 132,600,000 | 122,787,000 | 188,690,000 | 58,313,000 | 138,884,000 | 63,311,000 | 98,415,000 | 12,189,000 | 162,887,000 | 279,891,000 | 169,671,000 | 138,816,000 | 188,272,000 | 128,067,000 | 30,760,000 | 7,166,000 | 244,932,000 | 17,421,000 | -170,016,000 | 131,179,000 | 136,787,000 | 102,928,000 | -164,478,000 | 29,884,000 | 36,147,000 | 96,365,000 | 58,597,000 | 98,265,000 | 94,525,000 | 42,235,000 | 81,260,000 | 78,675,000 | 173,764,000 | -48,407,000 | 56,938,000 | -197,000 | 109,318,000 | 58,612,000 | 45,268,000 | 110,304,000 | 63,479,000 | 69,107,000 | 109,783,000 | 73,593,000 |
cash flows from investing activities, net of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
purchases and originations of loans, including cash paid for student loan trusts, net of cash and restricted cash acquired | -194,568,000 | -173,931,000 | |||||||||||||||||||||||||||||||||||||||||||||
purchases of loans from a related party | 0 | -136,667,000 | 0 | -35,000 | -68,000 | -567,000 | -6,626,000 | -1,049,000 | -1,202,000 | -629,000 | -1,116,000 | -19,731,000 | -72,421,000 | 0 | -33,901,000 | -41,217,000 | 0 | ||||||||||||||||||||||||||||||
net proceeds from loan repayments, claims, and capitalized interest | 457,279,000 | 423,817,000 | 434,668,000 | 620,032,000 | 977,639,000 | 1,147,413,000 | 649,005,000 | 561,552,000 | 663,865,000 | 684,962,000 | 1,439,086,000 | 1,162,167,000 | 944,742,000 | 848,188,000 | 1,093,131,000 | 963,000,000 | 410,370,000 | 637,275,000 | 434,550,000 | 409,511,000 | 1,282,939,000 | 517,347,000 | |||||||||||||||||||||||||
proceeds from sale of loans | 124,000 | 72,502,000 | 402,557,000 | -19,317,000 | 111,047,000 | 199,963,000 | 211,258,000 | 50,803,000 | 133,513,000 | 157,444,000 | 84,570,000 | 23,281,000 | 108,000 | 15,170,000 | 0 | 20,682,000 | 0 | 45,661,000 | 4,000 | 90,461,000 | 154,349,000 | 0 | |||||||||||||||||||||||||
proceeds from sale of loans to a related party | 242,000 | 59,939,000 | |||||||||||||||||||||||||||||||||||||||||||||
purchases of available-for-sale securities | -101,469,000 | -139,007,000 | -212,534,000 | -118,987,000 | -108,421,000 | -163,610,000 | -70,718,000 | -214,336,000 | -54,098,000 | -242,370,000 | -84,850,000 | -209,448,000 | -595,945,000 | -139,195,000 | -213,252,000 | -158,080,000 | -319,150,000 | -44,335,000 | -250,083,000 | -108,752,000 | -83,017,000 | -29,658,000 | 0 | 0 | -28,164,000 | -35,193,000 | -101,395,000 | -25,943,000 | -27,719,000 | ||||||||||||||||||
proceeds from sales of available-for-sale securities | 34,828,000 | 74,781,000 | 75,050,000 | 105,009,000 | 112,854,000 | 153,033,000 | 187,021,000 | 198,548,000 | 85,375,000 | 492,173,000 | 60,667,000 | 130,705,000 | 205,772,000 | 113,980,000 | 56,456,000 | 66,009,000 | 20,434,000 | 18,077,000 | 76,506,000 | 73,906,000 | 1,175,000 | 22,197,000 | -64,000 | -23,000 | 21,951,000 | 53,000,000 | 84,638,000 | 21,373,000 | 6,843,000 | ||||||||||||||||||
proceeds from beneficial interest in loan securitizations | 19,287,000 | 18,948,000 | 18,336,000 | 14,385,000 | 13,638,000 | 5,875,000 | 10,516,000 | 8,512,000 | 4,725,000 | 4,542,000 | 5,941,000 | 7,271,000 | 8,603,000 | 9,842,000 | 12,606,000 | 10,501,000 | 11,264,000 | ||||||||||||||||||||||||||||||
purchases of other investments and issuance of notes receivable | -81,737,000 | -80,091,000 | -196,124,000 | -90,150,000 | -126,465,000 | -70,975,000 | -165,286,000 | -39,503,000 | -69,620,000 | -70,509,000 | -70,573,000 | -45,373,000 | |||||||||||||||||||||||||||||||||||
proceeds from other investments and repayments of notes receivable | 439,161,000 | 15,668,000 | 18,789,000 | 25,460,000 | 42,815,000 | 10,820,000 | |||||||||||||||||||||||||||||||||||||||||
redemption of held-to-maturity debt securities | 4,020,000 | 3,776,000 | 12,888,000 | 6,849,000 | 3,262,000 | 1,779,000 | 1,686,000 | 1,406,000 | |||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -3,696,000 | -3,378,000 | 17,377,000 | -4,438,000 | -10,617,000 | -23,225,000 | -21,448,000 | -15,351,000 | -12,823,000 | -24,430,000 | -14,998,000 | -10,271,000 | -18,358,000 | -15,794,000 | -16,358,000 | -13,810,000 | -10,886,000 | -17,898,000 | -32,614,000 | -33,704,000 | -21,433,000 | -25,561,000 | -24,818,000 | -23,966,000 | -18,902,000 | -24,813,000 | -28,068,000 | -2,574,000 | -2,965,000 | -2,099,000 | -2,306,000 | -4,391,000 | -1,495,000 | -5,289,000 | -2,992,000 | -5,274,000 | -2,826,000 | -1,787,000 | -2,883,000 | -738,000 | -22,000 | -382,000 | -62,000 | -47,000 | -1,373,000 | -2,371,000 | -1,350,000 |
net cash from investing activities | 573,471,000 | 136,357,000 | 334,866,000 | 254,245,000 | 737,543,000 | 1,086,079,000 | 631,607,000 | 416,142,000 | 166,401,000 | 723,932,000 | 532,753,000 | 902,320,000 | 233,885,000 | 603,069,000 | 642,493,000 | 786,864,000 | -711,784,000 | 468,362,000 | -332,418,000 | 236,351,000 | 611,614,000 | 105,672,000 | 331,951,000 | 337,135,000 | 469,179,000 | 386,301,000 | 102,330,000 | -2,168,141,000 | 924,171,000 | 114,481,000 | 336,835,000 | 309,583,000 | 311,452,000 | 466,336,000 | 352,452,000 | 2,493,233,000 | 251,921,000 | -1,869,875,000 | -1,036,576,000 | 1,639,709,000 | 529,423,000 | 97,442,000 | -452,969,000 | 1,015,933,000 | -487,375,000 | 1,507,579,000 | -976,211,000 |
nelnet, inc. and subsidiaries | |||||||||||||||||||||||||||||||||||||||||||||||
consolidated statements of cash flows | |||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities, net of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
payments on bonds and notes payable | -770,635,000 | -347,217,000 | -633,744,000 | -727,533,000 | -1,007,221,000 | -1,276,160,000 | -609,244,000 | -579,294,000 | -1,002,198,000 | -1,415,424,000 | -1,304,082,000 | -1,339,385,000 | -777,427,000 | -918,270,000 | -1,204,188,000 | -1,406,059,000 | -489,220,000 | -584,303,000 | -326,271,000 | -729,504,000 | -810,506,000 | -1,263,204,000 | -980,027,000 | -1,711,368,000 | -1,075,476,000 | -932,007,000 | -901,008,000 | -1,649,080,000 | -1,274,892,000 | -827,719,000 | -692,408,000 | -552,152,000 | -603,508,000 | -692,156,000 | -1,090,797,000 | -3,022,961,000 | -763,523,000 | -749,738,000 | -1,028,622,000 | -2,665,743,000 | -1,794,398,000 | -1,563,514,000 | -620,595,000 | -1,551,044,000 | 115,626,000 | -4,894,090,000 | -550,318,000 |
proceeds from issuance of bonds and notes payable | -54,385,000 | 85,000,000 | -18,071,000 | 18,108,000 | 4,914,000 | -49,880,000 | 601,264,000 | 204,884,000 | 888,163,000 | 253,460,000 | 146,419,000 | 13,512,000 | 209,154,000 | 623,584,000 | 1,107,021,000 | 7,800,000 | 424,165,000 | 208,164,000 | 58,972,000 | 1,193,388,000 | 587,609,000 | 1,318,177,000 | 521,654,000 | 570,532,000 | 756,700,000 | 3,834,700,000 | 295,690,000 | 656,893,000 | 279,667,000 | 104,740,000 | 250,090,000 | 212,457,000 | 533,097,000 | 347,773,000 | 517,881,000 | 2,524,743,000 | 2,061,893,000 | 926,861,000 | 1,176,863,000 | 1,544,738,000 | 1,039,942,000 | 415,317,000 | 464,405,000 | 3,301,721,000 | 1,459,422,000 | ||
payments of debt issuance costs | -3,930,000 | -69,000 | -136,000 | -1,498,000 | -662,000 | -31,000 | -3,511,000 | -19,000 | -2,045,000 | -169,000 | -2,635,000 | -309,000 | -539,000 | -312,000 | -315,000 | -3,743,000 | -2,421,000 | -614,000 | -1,530,000 | -1,281,000 | -1,009,000 | -4,854,000 | -3,879,000 | -5,012,000 | -2,739,000 | -2,776,000 | -1,650,000 | -10,567,000 | -2,037,000 | -3,998,000 | -1,595,000 | 0 | -776,000 | -46,000 | -1,460,000 | -1,347,000 | -928,000 | -2,974,000 | -4,069,000 | -3,363,000 | -3,046,000 | -1,382,000 | -1,448,000 | -108,000 | -144,000 | -11,450,000 | -3,184,000 |
increase in bank deposits | 68,635,000 | 127,276,000 | 115,373,000 | 180,286,000 | 88,411,000 | 58,462,000 | 25,546,000 | -12,993,000 | 55,279,000 | -15,555,000 | 110,497,000 | -7,649,000 | 104,427,000 | 139,732,000 | 143,664,000 | -2,190,000 | 91,011,000 | 57,197,000 | |||||||||||||||||||||||||||||
decrease in due to customers | 49,687,000 | -99,176,000 | 15,457,000 | 114,070,000 | -150,712,000 | -67,642,000 | -89,884,000 | -70,849,000 | 17,543,000 | 48,634,000 | -217,851,000 | 62,546,000 | -153,207,000 | -58,606,000 | |||||||||||||||||||||||||||||||||
dividends paid | -10,161,000 | -10,161,000 | -10,160,000 | -10,148,000 | -10,158,000 | -10,370,000 | -10,370,000 | -9,701,000 | -9,694,000 | -9,654,000 | -9,648,000 | -8,925,000 | -8,972,000 | -9,063,000 | -9,138,000 | -8,407,000 | -8,475,000 | -8,437,000 | -8,435,000 | -7,664,000 | -7,733,000 | -7,946,000 | -7,939,000 | -7,143,000 | -7,171,000 | -7,232,000 | -6,506,000 | -52,051,000 | -4,737,000 | -4,737,000 | -4,712,000 | -4,713,000 | -4,811,000 | -4,852,000 | -3,387,000 | -23,695,000 | -3,435,000 | -3,507,000 | -3,494,000 | 0 | 0 | 0 | -3,458,000 | ||||
repurchases of common stock | -21,360,000 | -4,458,000 | -403,000 | -576,000 | -46,842,000 | -35,469,000 | -23,718,000 | -543,000 | -465,000 | -3,302,000 | -4,461,000 | -14,293,000 | -46,032,000 | -32,899,000 | -30,625,000 | -25,078,000 | -399,000 | -2,009,000 | -213,000 | -4,618,000 | -67,274,000 | -1,253,000 | -149,000 | -221,000 | -23,683,000 | -16,358,000 | -11,418,000 | -21,293,000 | -206,000 | -199,000 | -1,116,000 | -6,004,000 | -20,595,000 | -225,000 | -310,000 | -133,000 | -26,614,000 | -12,822,000 | -236,000 | -260,000 | -108,000 | -26,000 | -36,000 | -766,000 | -103,000 | -179,000 | -488,000 |
proceeds from issuance of common stock | 579,000 | 341,000 | 522,000 | 457,000 | 593,000 | 374,000 | 465,000 | 425,000 | 495,000 | 395,000 | 427,000 | 405,000 | 366,000 | 435,000 | 357,000 | 419,000 | 308,000 | 381,000 | 403,000 | 469,000 | 370,000 | 411,000 | 381,000 | 447,000 | 263,000 | 461,000 | 274,000 | 131,000 | 100,000 | 133,000 | 116,000 | 106,000 | 141,000 | 141,000 | 124,000 | 157,000 | 124,000 | 130,000 | 117,000 | 120,000 | 98,000 | 113,000 | 118,000 | 144,000 | 143,000 | ||
acquisition of noncontrolling interest | 0 | 0 | 1,400,000 | 0 | -13,449,000 | ||||||||||||||||||||||||||||||||||||||||||
issuance of noncontrolling interests | 6,711,000 | 8,869,000 | 28,380,000 | 23,849,000 | 13,298,000 | 14,098,000 | 55,808,000 | 18,563,000 | 12,817,000 | 1,201,000 | 36,397,000 | 14,238,000 | 3,138,000 | 2,004,000 | 36,811,000 | 6,425,000 | 5,540,000 | 1,940,000 | 512,000 | ||||||||||||||||||||||||||||
distribution to noncontrolling interests | -1,501,000 | -1,850,000 | -2,388,000 | -1,252,000 | -1,536,000 | -799,000 | -2,138,000 | -599,000 | -927,000 | -993,000 | -2,395,000 | -454,000 | -334,000 | -365,000 | -330,000 | -125,000 | -321,000 | -102,000 | -428,000 | -327,000 | -311,000 | -22,000 | -62,000 | -60,000 | -91,000 | -22,000 | -19,000 | ||||||||||||||||||||
net cash from financing activities | -685,894,000 | -326,445,000 | -482,757,000 | -435,958,000 | -868,443,000 | -1,382,499,000 | -478,644,000 | -591,735,000 | -326,560,000 | -1,306,259,000 | -245,940,000 | -1,205,923,000 | -535,410,000 | -805,226,000 | -854,610,000 | -815,174,000 | 703,044,000 | -528,147,000 | 349,492,000 | -534,761,000 | -829,491,000 | -83,480,000 | -403,554,000 | -413,678,000 | -588,637,000 | -387,402,000 | -177,076,000 | 2,101,777,000 | -986,082,000 | -179,622,000 | -419,276,000 | -458,023,000 | -379,429,000 | -484,681,000 | -669,783,000 | -2,704,831,000 | -164,740,000 | 1,755,832,000 | 1,025,788,000 | -1,745,877,000 | -620,591,000 | -19,970,000 | 396,461,000 | -1,214,619,000 | 603,448,000 | -1,605,450,000 | 913,693,000 |
effect of exchange rate changes on cash and restricted cash | 312,000 | 26,000 | -640,000 | 290,000 | 76,000 | -163,000 | |||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents, and restricted cash | -30,351,000 | -98,893,000 | -44,385,000 | 2,580,000 | -84,668,000 | -21,480,000 | -84,018,000 | -459,573,000 | -16,523,000 | -11,204,000 | -19,774,000 | -179,023,000 | -122,263,000 | -140,766,000 | -16,794,000 | ||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, beginning of period | 0 | 931,020,000 | 0 | 0 | 0 | 1,025,491,000 | 0 | 0 | 0 | 1,357,616,000 | 0 | 0 | 0 | 1,194,189,000 | 0 | 0 | 0 | 958,395,000 | 0 | 0 | 1,222,601,000 | 0 | 0 | 1,192,391,000 | 942,066,000 | ||||||||||||||||||||||
cash, cash equivalents, and restricted cash, end of period | -30,351,000 | 832,127,000 | 32,002,000 | -44,385,000 | 2,580,000 | 940,823,000 | 232,946,000 | -21,480,000 | -84,018,000 | 898,043,000 | 314,287,000 | -130,713,000 | -3,624,000 | 1,177,666,000 | -56,889,000 | 173,705,000 | 130,182,000 | 947,191,000 | -19,774,000 | -179,023,000 | 1,100,338,000 | 84,210,000 | 2,372,000 | 1,051,625,000 | 925,272,000 | ||||||||||||||||||||||
deferred income tax expense | 4,316,000 | -22,993,000 | 7,743,000 | 10,447,000 | 39,443,000 | 22,544,000 | 14,905,000 | 2,768,000 | 15,405,000 | 16,883,000 | 100,000 | -280,000 | 7,509,000 | 1,323,000 | |||||||||||||||||||||||||||||||||
increase in other assets | -18,886,000 | -1,720,000 | -9,760,000 | 62,016,000 | -65,276,000 | -6,052,000 | -1,963,000 | 10,911,000 | -20,433,000 | 30,781,000 | -32,324,000 | -51,071,000 | -11,678,000 | ||||||||||||||||||||||||||||||||||
decrease in other liabilities | -37,102,000 | -12,420,000 | -50,218,000 | -5,187,000 | -3,729,000 | -376,000 | -11,824,000 | -3,288,000 | -10,375,000 | 15,230,000 | -42,047,000 | 1,072,000 | -5,741,000 | -26,027,000 | |||||||||||||||||||||||||||||||||
proceeds from termination of derivative instruments | 0 | 0 | 0 | 164,079,000 | 0 | 23,765,000 | 0 | 2,119,000 | 4,965,000 | 7,856,000 | 0 | 7,547,000 | |||||||||||||||||||||||||||||||||||
proceeds from (payments to) clearinghouse - initial and variation margin | 1,662,000 | 4,054,000 | 50,261,000 | 2,593,000 | 359,000 | 38,081,000 | |||||||||||||||||||||||||||||||||||||||||
loss on sale of loans | -42,000 | 106,000 | 196,000 | 206,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity securities, net of purchases | |||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax (benefit) expense | -27,251,000 | -8,568,000 | -2,394,000 | -13,750,000 | 2,327,000 | 5,431,000 | -12,216,000 | -2,807,000 | -7,190,000 | ||||||||||||||||||||||||||||||||||||||
decrease (increase) in loan and investment accrued interest receivable | 41,604,000 | -10,510,000 | 10,694,000 | ||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | 2,728,000 | 26,344,000 | 18,442,000 | -4,595,000 | 3,867,000 | -10,577,000 | 52,185,000 | 177,000 | -4,760,000 | -7,778,000 | 6,551,000 | -2,653,000 | |||||||||||||||||||||||||||||||||||
decrease (increase) in other assets | 29,224,000 | 10,443,000 | -3,179,000 | 39,691,000 | -3,501,000 | -8,371,000 | 31,363,000 | 49,415,000 | 356,000 | 1,016,000 | 7,236,000 | ||||||||||||||||||||||||||||||||||||
increase in accrued interest payable | -4,534,000 | -1,000,000 | 465,000 | 1,552,000 | -1,675,000 | 14,253,000 | 8,833,000 | 5,747,000 | 2,650,000 | -3,411,000 | -5,060,000 | -4,126,000 | -5,687,000 | 479,000 | 4,213,000 | 2,669,000 | -1,147,000 | -10,536,000 | |||||||||||||||||||||||||||||
purchases and originations of loans, including purchase of student loan residual interests | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of held-to-maturity debt securities | -1,100,000 | -8,436,000 | |||||||||||||||||||||||||||||||||||||||||||||
business acquisitions, net of cash and restricted cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||
years ended december 31, 2024, 2023, and 2022 | |||||||||||||||||||||||||||||||||||||||||||||||
increase in due to customers | 41,797,000 | -103,011,000 | 11,393,000 | 51,400,000 | 128,447,000 | ||||||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents, and restricted cash | 314,287,000 | -130,713,000 | -56,889,000 | 173,705,000 | 84,210,000 | ||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
payments to clearinghouse - initial and variation margin | 4,048,000 | -4,067,000 | -20,386,000 | ||||||||||||||||||||||||||||||||||||||||||||
loss on investments | -390,000 | 20,680,000 | 22,916,000 | 24,344,000 | 406,000 | 2,801,000 | |||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
purchases and originations of loans | -181,020,000 | -273,528,000 | -157,047,000 | -178,748,000 | -144,387,000 | -122,691,000 | -289,177,000 | -912,900,000 | -142,632,000 | -235,152,000 | -161,334,000 | -172,830,000 | -105,202,000 | -888,244,000 | -152,329,000 | ||||||||||||||||||||||||||||||||
purchases of restricted available-for-sale securities | 0 | -5,001,000 | -18,287,000 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of restricted available-for-sale securities | 620,000 | 320,000 | 340,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
loan discount accretion | -7,433,000 | -8,286,000 | -7,115,000 | -7,736,000 | -7,676,000 | -39,517,000 | -8,409,000 | -9,627,000 | -9,927,000 | 17,058,000 | -10,442,000 | -7,388,000 | -7,218,000 | -7,471,000 | -8,618,000 | -9,754,000 | -9,442,000 | -8,270,000 | -8,748,000 | -9,113,000 | -9,693,000 | -11,691,000 | |||||||||||||||||||||||||
gain on sale of loans | 41,000 | -6,988,000 | -5,362,000 | -15,511,000 | -11,812,000 | 2,713,000 | -2,627,000 | 0 | -2,989,000 | -14,817,000 | -36,000 | -47,000 | -33,000 | 0 | 0 | -1,345,000 | |||||||||||||||||||||||||||||||
loss on investments, net of gains | 8,348,000 | ||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of business acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
provision (negative provision) for loan losses | 34,275,000 | 27,801,000 | 9,666,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain on investments | 11,038,000 | ||||||||||||||||||||||||||||||||||||||||||||||
impairment expense | 26,951,000 | 0 | 332,000 | 34,087,000 | 0 | 0 | 0 | 18,834,000 | |||||||||||||||||||||||||||||||||||||||
increase in accounts receivable | -84,845,000 | 7,309,000 | -5,615,000 | -3,831,000 | -48,312,000 | -1,665,000 | 10,599,000 | -16,571,000 | -4,398,000 | -2,786,000 | -561,000 | -198,000 | 16,099,000 | -11,277,000 | 3,268,000 | -18,661,000 | 2,838,000 | -9,531,000 | -487,000 | ||||||||||||||||||||||||||||
cash flows from investing activities, net of business acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from and sale of beneficial interest in loan securitizations | 9,791,000 | 11,734,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities, net of business acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate changes on cash | 222,000 | -122,000 | 7,000 | -91,000 | 287,000 | -268,000 | -348,000 | 169,000 | 54,000 | -67,000 | -31,000 | -77,000 | |||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of business acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity securities | 0 | 0 | 75,000 | ||||||||||||||||||||||||||||||||||||||||||||
proceeds from other investments | 15,365,000 | 3,289,000 | 11,114,000 | 22,845,000 | 18,569,000 | 14,179,000 | 9,776,000 | -17,813,000 | 41,813,000 | 57,531,000 | 110,290,000 | 4,483,000 | 1,758,000 | 3,635,000 | 3,135,000 | ||||||||||||||||||||||||||||||||
business acquisition, net of cash acquired | -109,152,000 | 0 | 0 | -3,000,000 | |||||||||||||||||||||||||||||||||||||||||||
increase in loan and investment accrued interest receivable | -22,294,000 | -1,443,000 | -40,374,000 | -114,000 | -33,898,000 | ||||||||||||||||||||||||||||||||||||||||||
gain from deconsolidation of allo, including cash impact | |||||||||||||||||||||||||||||||||||||||||||||||
(gain) income from repurchases of debt | 0 | -160,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale (purchases) of equity securities | -22,000 | 465,000 | 41,826,000 | 572,000 | |||||||||||||||||||||||||||||||||||||||||||
proceeds from clearinghouse - initial and variation margin, net of payments | 93,826,000 | -16,027,000 | 149,649,000 | ||||||||||||||||||||||||||||||||||||||||||||
benefit from beneficial interests and impairment expense | 4,137,000 | ||||||||||||||||||||||||||||||||||||||||||||||
business acquisitions, net of cash acquired | 0 | 0 | 0 | -18,000,000 | |||||||||||||||||||||||||||||||||||||||||||
provision (negative provision) for beneficial interests and impairment expense | |||||||||||||||||||||||||||||||||||||||||||||||
negative benefit from loan losses | -435,000 | ||||||||||||||||||||||||||||||||||||||||||||||
negative benefit from beneficial interests | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of other investments | -73,944,000 | -87,230,000 | -38,653,000 | -56,421,000 | -71,590,000 | -45,632,000 | -4,986,000 | -84,706,000 | -32,892,000 | ||||||||||||||||||||||||||||||||||||||
(negative provision) benefit from loan losses | -1,579,000 | 5,827,000 | 374,000 | -17,048,000 | |||||||||||||||||||||||||||||||||||||||||||
payments to terminate derivative instruments | -12,688,000 | ||||||||||||||||||||||||||||||||||||||||||||||
gain from sale of loans | 0 | -3,444,000 | -18,206,000 | -15,549,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||
gain from investments | -3,518,000 | -1,105,000 | 23,711,000 | 10,636,000 | |||||||||||||||||||||||||||||||||||||||||||
loss on (gain from) repurchases and extinguishments of debt | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity securities | |||||||||||||||||||||||||||||||||||||||||||||||
payments to extinguish debt | |||||||||||||||||||||||||||||||||||||||||||||||
gain from repurchases of debt | 3,269,000 | ||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity securities - trading | -21,827,000 | -6,252,000 | -13,512,000 | ||||||||||||||||||||||||||||||||||||||||||||
(negative provision) benefit from beneficial interests and impairment expense | 500,000 | -2,436,000 | |||||||||||||||||||||||||||||||||||||||||||||
income from investments | 13,849,000 | 4,046,000 | |||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in the carrying amount of rou asset | 1,418,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities, net of acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
(payments to) proceeds from termination of derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
(gain from) loss on repurchases and extinguishment of debt | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of loans | -427,060,000 | -159,649,000 | -463,583,000 | -409,404,000 | -647,334,000 | -363,750,000 | -652,492,000 | -344,631,000 | -610,855,000 | ||||||||||||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash, end of year | |||||||||||||||||||||||||||||||||||||||||||||||
payments from termination of derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
(gain) loss on repurchases and extinguishment of debt | -105,000 | ||||||||||||||||||||||||||||||||||||||||||||||
increase in accrued interest receivable | -90,109,000 | -33,167,000 | 3,278,000 | -12,897,000 | -8,245,000 | -36,722,000 | -20,588,000 | -61,253,000 | -6,929,000 | ||||||||||||||||||||||||||||||||||||||
increase in the carrying amount of rou asset | -1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||
unrealized foreign currency transaction adjustment | |||||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 874,000 | 14,014,000 | |||||||||||||||||||||||||||||||||||||||||||||
purchases of investments and issuance of notes receivable | -32,650,000 | -44,286,000 | -10,344,000 | -15,970,000 | -16,370,000 | ||||||||||||||||||||||||||||||||||||||||||
proceeds from investments and notes receivable | 15,653,000 | 30,088,000 | 23,012,000 | 1,719,000 | 9,718,000 | ||||||||||||||||||||||||||||||||||||||||||
business (acquisitions) sale, net of cash and restricted cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
gain from debt repurchases | -359,000 | -2,973,000 | -148,000 | 0 | 0 | 0 | -6,962,000 | ||||||||||||||||||||||||||||||||||||||||
gain from investments and notes receivable | -1,921,000 | -4,121,000 | 1,151,000 | ||||||||||||||||||||||||||||||||||||||||||||
net proceeds from loan repayments, claims, capitalized interest, and other | 739,072,000 | 1,119,088,000 | 769,996,000 | 863,270,000 | |||||||||||||||||||||||||||||||||||||||||||
business acquisition, net of cash and restricted cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||
payment of debt extinguishment costs | -12,636,000 | ||||||||||||||||||||||||||||||||||||||||||||||
derivative market value adjustment | -60,033,000 | -39,516,000 | 5,426,000 | 78,758,000 | -16,835,000 | 31,830,000 | 87,341,000 | -2,208,000 | -66,450,000 | -17,405,000 | -73,662,000 | 100,631,000 | 67,570,000 | 13,060,000 | -42,182,000 | -29,852,000 | 52,122,000 | -33,823,000 | 119,861,000 | -11,459,000 | -36,003,000 | ||||||||||||||||||||||||||
proceeds (payments) from termination of derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
payments to enter into derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from clearinghouse - initial and variation margin | |||||||||||||||||||||||||||||||||||||||||||||||
(gain) income from investments and notes receivable | |||||||||||||||||||||||||||||||||||||||||||||||
increase in loan accrued interest receivable | -59,038,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of business | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from clearinghouse to settle variation margin | 62,689,000 | ||||||||||||||||||||||||||||||||||||||||||||||
gain from equity securities, net of losses | -6,838,000 | ||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including debt discounts and student loan premiums and deferred origination costs | |||||||||||||||||||||||||||||||||||||||||||||||
student loan discount accretion | |||||||||||||||||||||||||||||||||||||||||||||||
(gain) income from sales of available-for-sale securities | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds (purchases) related to trading securities | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of student loans | -146,071,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from student loan repayments, claims, capitalized interest, and other | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of student loans | 14,944,000 | 32,184,000 | 27,373,000 | 32,592,000 | 26,166,000 | 47,000 | 0 | 95,131,000 | 2,175,236,000 | 6,155,000 | 1,004,000 | 20,032,000 | 1,766,917,000 | 549,835,000 | 216,000 | 125,000 | 539,987,000 | 0 | 426,739,000 | 841,087,000 | |||||||||||||||||||||||||||
purchases of investments and loans receivable and issuance of notes receivable | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from investments and other receivables | |||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in restricted cash | |||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -24,247,000 | 68,204,000 | -235,664,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 42,570,000 | 0 | 0 | 283,801,000 | 0 | 0 | 338,181,000 | 0 | 0 | 189,847,000 | 0 | 0 | 111,746,000 | ||||||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 37,419,000 | -4,445,000 | 60,700,000 | -24,247,000 | 68,204,000 | 48,137,000 | 41,600,000 | -55,318,000 | 330,079,000 | -32,534,000 | 123,122,000 | 243,705,000 | 186,553,000 | 14,283,000 | 124,171,000 | ||||||||||||||||||||||||||||||||
cash disbursements made for: | |||||||||||||||||||||||||||||||||||||||||||||||
interest | |||||||||||||||||||||||||||||||||||||||||||||||
income taxes, net of refunds | |||||||||||||||||||||||||||||||||||||||||||||||
foreign currency transaction adjustment | 25,747,000 | 20,798,000 | -59,226,000 | 32,242,000 | -43,608,000 | -73,452,000 | 19,020,000 | 65,334,000 | -22,113,000 | 106,467,000 | -93,400,000 | -71,675,000 | -18,325,000 | 39,356,000 | 63,865,000 | -47,242,000 | -12,526,000 | -128,890,000 | -4,407,000 | 92,937,000 | |||||||||||||||||||||||||||
net increase in cash and cash equivalents | -27,643,000 | 37,419,000 | -4,445,000 | 18,130,000 | -32,560,000 | 41,600,000 | -55,318,000 | -8,102,000 | 3,888,000 | -32,534,000 | 123,122,000 | 53,858,000 | -135,160,000 | 186,553,000 | 14,283,000 | 12,425,000 | |||||||||||||||||||||||||||||||
supplemental noncash operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
increase in other assets related to centrally cleared variation margin settlements on derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from termination of derivative instruments, net of payments | |||||||||||||||||||||||||||||||||||||||||||||||
payment to enter into interest rate caps | |||||||||||||||||||||||||||||||||||||||||||||||
gain from sales of available-for-sale securities | |||||||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in accrued interest receivable | 22,670,000 | -9,121,000 | 6,003,000 | 9,668,000 | 58,224,000 | -28,558,000 | 25,000,000 | 66,778,000 | |||||||||||||||||||||||||||||||||||||||
purchases of student loans and student loan residual interests | |||||||||||||||||||||||||||||||||||||||||||||||
increase in restricted cash and investments | 90,099,000 | 7,394,000 | -207,002,000 | -91,631,000 | -127,472,000 | 23,945,000 | -22,813,000 | 57,969,000 | -102,366,000 | 136,032,000 | -221,240,000 | 84,743,000 | |||||||||||||||||||||||||||||||||||
cash flows from financing activities, net of borrowings assumed: | |||||||||||||||||||||||||||||||||||||||||||||||
noncash activity: | |||||||||||||||||||||||||||||||||||||||||||||||
investing activity - student loans and other assets acquired | |||||||||||||||||||||||||||||||||||||||||||||||
financing activity - borrowings and other liabilities assumed in acquisition of student loans | |||||||||||||||||||||||||||||||||||||||||||||||
payments for purchases of trading securities | |||||||||||||||||||||||||||||||||||||||||||||||
(payments for) proceeds from (purchases) sales of trading securities | |||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to noncontrolling interest | 19,000 | 124,000 | 136,000 | 152,000 | |||||||||||||||||||||||||||||||||||||||||||
purchases of trading investments | |||||||||||||||||||||||||||||||||||||||||||||||
decrease in accrued interest receivable | -39,662,000 | 18,277,000 | 10,245,000 | 12,023,000 | -4,080,000 | 3,157,000 | 83,563,000 | ||||||||||||||||||||||||||||||||||||||||
purchase of student loans from a related party | |||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from student loan repayments, claims, capitalized interest, participations, and other | 612,739,000 | 1,050,395,000 | 852,576,000 | 597,034,000 | 456,990,000 | 428,385,000 | 719,738,000 | 630,606,000 | 434,281,000 | 615,431,000 | 365,685,000 | 330,526,000 | 443,010,000 | 734,445,000 | 708,897,000 | 476,624,000 | 637,195,000 | 424,315,000 | |||||||||||||||||||||||||||||
decrease in restricted cash and investments | |||||||||||||||||||||||||||||||||||||||||||||||
issuance of noncontrolling interest | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
distribution to noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of asset acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the termination/amendment of derivative instruments, net of payments | |||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities, net of asset acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of student loans from a related party | -9,000 | -69,000 | -221,000 | -4,000 | |||||||||||||||||||||||||||||||||||||||||||
decrease (increase) in restricted cash and investments | -13,104,000 | 42,982,000 | 173,144,000 | ||||||||||||||||||||||||||||||||||||||||||||
asset acquisitions, including contingency payments | |||||||||||||||||||||||||||||||||||||||||||||||
payments received on employee stock notes receivable | 368,000 | 0 | 0 | 772,000 | 0 | 0 | 80,000 | 0 | 199,000 | 0 | 0 | 0 | 0 | 177,000 | 398,000 | ||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||||||||||||||||||||||||||||
payments to terminate and/or amend derivative instruments, net of proceeds | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of student loans - held for sale | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 55,599,000 | 58,184,000 | 59,485,000 | 61,338,000 | 52,950,000 | 52,160,000 | 47,333,000 | 53,674,000 | 68,873,000 | 53,006,000 | 49,777,000 | 54,291,000 | 86,502,000 | 116,831,000 | 177,210,000 | 242,171,000 | 224,891,000 | 234,674,000 | 354,904,000 | ||||||||||||||||||||||||||||
income taxes paid, net of refunds | 27,960,000 | 29,685,000 | 54,193,000 | 2,920,000 | 35,540,000 | 34,309,000 | 31,038,000 | 32,293,000 | 28,181,000 | 25,887,000 | 26,764,000 | 25,123,000 | 31,567,000 | 39,625,000 | 22,203,000 | 8,096,000 | -244,000 | 10,176,000 | 8,783,000 | 5,343,000 | |||||||||||||||||||||||||||
purchases of cost-method investments | |||||||||||||||||||||||||||||||||||||||||||||||
business acquisition contingency payment | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, net of business and asset acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
(payments) proceeds to terminate and/or amend derivative instruments | 425,000 | ||||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans - held for sale | |||||||||||||||||||||||||||||||||||||||||||||||
change in investments - trading securities | 277,000 | -1,795,000 | 523,000 | -752,000 | -946,000 | -18,170,000 | 6,055,000 | 5,517,000 | -10,154,000 | -2,065,000 | |||||||||||||||||||||||||||||||||||||
other non-cash items | 304,000 | 1,923,000 | -605,000 | -697,000 | 677,000 | -232,000 | 297,000 | -189,000 | 611,000 | -697,000 | 241,000 | 254,000 | -1,593,000 | -5,123,000 | 7,668,000 | 1,024,000 | 530,000 | 914,000 | 153,000 | 191,000 | |||||||||||||||||||||||||||
cash flows from investing activities, net of business and asset acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans | -176,212,000 | ||||||||||||||||||||||||||||||||||||||||||||||
business and asset acquisitions, including contingency payments | |||||||||||||||||||||||||||||||||||||||||||||||
distribution from equity method investment | |||||||||||||||||||||||||||||||||||||||||||||||
distribution made to noncontrolling interest | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including loan and debt premiums/discounts and deferred origination costs | 18,153,000 | 18,003,000 | 17,521,000 | ||||||||||||||||||||||||||||||||||||||||||||
gain from sale of available-for-sale securities | |||||||||||||||||||||||||||||||||||||||||||||||
business and asset acquisition contingency payments | -1,550,000 | ||||||||||||||||||||||||||||||||||||||||||||||
payments on bonds payable due to a related party | 0 | 0 | 0 | -107,050,000 | |||||||||||||||||||||||||||||||||||||||||||
investing activity - student loans acquired | |||||||||||||||||||||||||||||||||||||||||||||||
operating activity - other assets acquired and other liabilities assumed | |||||||||||||||||||||||||||||||||||||||||||||||
financing activity - borrowings assumed in acquisition of student loans and other assets | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds to terminate and/or amend derivative instruments | 1,238,000 | 0 | 0 | 12,369,000 | 13,909,000 | 855,000 | 50,000 | 2,388,000 | 1,382,000 | 50,000 | |||||||||||||||||||||||||||||||||||||
issuance of minority membership interest | 0 | 5,000 | |||||||||||||||||||||||||||||||||||||||||||||
payments to terminate and/or amend derivative instruments | -174,000 | -9,546,000 | -381,000 | -141,000 | -2,586,000 | 0 | -3,359,000 | 0 | 50,000 | -11,760,000 | |||||||||||||||||||||||||||||||||||||
originations and purchases of student loans, including loan premiums and deferred origination costs, net of discounts | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of student loans to a related party | 14,996,000 | 21,419,000 | 20,017,000 | 20,016,000 | |||||||||||||||||||||||||||||||||||||||||||
business and asset acquisitions, net of cash acquired, including contingency payments | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of bonds payable due to a related party | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities, | |||||||||||||||||||||||||||||||||||||||||||||||
net of business and asset acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including loan premiums/discount and deferred origination costs | 18,621,000 | 16,877,000 | 18,964,000 | ||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans-held for sale | |||||||||||||||||||||||||||||||||||||||||||||||
accrued litigation settlement | |||||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans, including loan premiums/discounts | |||||||||||||||||||||||||||||||||||||||||||||||
and deferred origination costs | -672,323,000 | ||||||||||||||||||||||||||||||||||||||||||||||
purchases of student loans, including loan premiums, from a related party | -30,000 | 0 | -29,000 | -535,907,000 | -7,972,000 | -19,257,000 | -6,589,000 | -13,803,000 | 0 | 0 | -35,100,000 | -177,788,000 | |||||||||||||||||||||||||||||||||||
business and asset acquisitions, net of cash acquired, including contingency payments/receipts | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non-cash operating, investing, and financing activities regarding the company's acquisition of student loans from an affiliate of greystone & co., inc. are contained in note 2. | |||||||||||||||||||||||||||||||||||||||||||||||
see accompanying notes to consolidated financial statements. | |||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities, net of business acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans, including loan premiums/discounts and deferred origination costs | -426,725,000 | -235,599,000 | |||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income to net cash from operating activities, net of business acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
business acquisitions, net of cash acquired, including contingency payments | -7,193,000 | ||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | 837,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 59,063,000 | 46,404,000 | 30,160,000 | 23,785,000 | 42,724,000 | -69,825,000 | |||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash from operating activities, net of business acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
change in value of put options issued in business acquisitions | 0 | 2,945,000 | 111,000 | 427,000 | |||||||||||||||||||||||||||||||||||||||||||
gain from repurchase of bonds and notes payable | -16,062,000 | -9,885,000 | -8,759,000 | -10,177,000 | -22,498,000 | ||||||||||||||||||||||||||||||||||||||||||
(gain) loss on sale of student loans | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from operating activities - continuing operations | 110,056,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from operating activities - discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
originations, purchases, and consolidations of student loans, including loan premiums and deferred origination costs | -494,862,000 | -972,450,000 | -317,647,000 | -887,924,000 | -305,939,000 | -1,174,366,000 | |||||||||||||||||||||||||||||||||||||||||
purchase of equity method investment | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from investing activities - continuing operations | 1,639,709,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from investing activities - discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
payments on bonds and notes payable due to a related party | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of bonds and notes payable due to a related party | |||||||||||||||||||||||||||||||||||||||||||||||
payment on settlement of put option | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from financing activities - continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from financing activities - discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
interest paid: | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income to net cash from operating | |||||||||||||||||||||||||||||||||||||||||||||||
activities, net of business acquisition: | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including loan premiums | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds received to terminate and/or amend derivative instruments | |||||||||||||||||||||||||||||||||||||||||||||||
originations and purchases of student loans, including loan | |||||||||||||||||||||||||||||||||||||||||||||||
premiums/discounts and deferred origination costs | |||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from student loan repayments, claims, | |||||||||||||||||||||||||||||||||||||||||||||||
capitalized interest, participations, and other | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including loan premiums and deferred origination costs | 23,329,000 | 26,864,000 | 27,920,000 | 30,228,000 | 27,756,000 | 30,134,000 | 33,661,000 | 33,632,000 | 35,360,000 | 38,952,000 | |||||||||||||||||||||||||||||||||||||
originations and purchases of student loans, including loan premiums and deferred origination costs | -1,027,883,000 | ||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash provided | |||||||||||||||||||||||||||||||||||||||||||||||
by operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of business | |||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of equity method investment | |||||||||||||||||||||||||||||||||||||||||||||||
originations, purchases, and consolidations of student loans, including loan premiums | |||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity method investments | 0 | 0 | -1,270,000 | -1,718,000 | |||||||||||||||||||||||||||||||||||||||||||
distributions from equity method investments | |||||||||||||||||||||||||||||||||||||||||||||||
sale of business, net of cash sold | |||||||||||||||||||||||||||||||||||||||||||||||
business acquisitions - contingent consideration and purchase price adjustments | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity method investment | |||||||||||||||||||||||||||||||||||||||||||||||
payments from issuance of notes payable due to a related party | |||||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rate fluctuations on cash | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of noncash financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||
notes payable assumed in connection with an acquisition of an entity under common control | |||||||||||||||||||||||||||||||||||||||||||||||
common stock issued in consideration for notes receivable | |||||||||||||||||||||||||||||||||||||||||||||||
business acquisition - contingent consideration | |||||||||||||||||||||||||||||||||||||||||||||||
(payments) proceeds from issuance of notes payable due to a related party | 0 | 0 | -21,520,000 | ||||||||||||||||||||||||||||||||||||||||||||
net cash flows used in financing activities - continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows used in financing activities - discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||
change in value of put options issued in business combinations | |||||||||||||||||||||||||||||||||||||||||||||||
gain from purchase of debt | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from operating activities — continuing operations | 63,526,000 | 74,943,000 | |||||||||||||||||||||||||||||||||||||||||||||
net cash flows from operating activities — discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
business acquisition — contingent consideration | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from investing activities — continuing operations | 1,015,933,000 | -976,211,000 | |||||||||||||||||||||||||||||||||||||||||||||
net cash flows from investing activities — discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
net cash flows from financing activities — continuing operations | -1,214,619,000 | 913,693,000 | |||||||||||||||||||||||||||||||||||||||||||||
net cash flows from financing activities — discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||
gain from purchase of unsecured debt | -8,075,000 | ||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash from operating activities, net of business acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of floor contracts | |||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of student loans | 3,988,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
loans to employees for purchases of common stock | |||||||||||||||||||||||||||||||||||||||||||||||
notes payable assumed in connection with acquisition of entities under common control | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds (payments) from issuance of notes payable due to a related party | 23,521,000 | -2,052,000 | 11,321,000 | ||||||||||||||||||||||||||||||||||||||||||||
payments to terminate floor contracts | |||||||||||||||||||||||||||||||||||||||||||||||
increase in restricted cash | 787,977,000 | -858,209,000 | |||||||||||||||||||||||||||||||||||||||||||||
purchases of restricted investments | -80,936,000 | -89,576,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from maturities of restricted investments | 81,284,000 | 79,394,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of business, net of cash sold | |||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of student loans and reduction in fair value related to loans held for sale | 47,474,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from termination of interest rate swaps | |||||||||||||||||||||||||||||||||||||||||||||||
purchase of loan origination rights | |||||||||||||||||||||||||||||||||||||||||||||||
consideration paid to expand customer relationships | |||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization, including amortization of loan premiums and deferred origination costs | |||||||||||||||||||||||||||||||||||||||||||||||
income from equity method investments | |||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of fixed asset | |||||||||||||||||||||||||||||||||||||||||||||||
provision (recovery) for loan losses | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of fixed asset | |||||||||||||||||||||||||||||||||||||||||||||||
purchase of equity method investments | |||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of notes payable due to a related party | |||||||||||||||||||||||||||||||||||||||||||||||
note payable assumed in connection with purchase of property | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of noncash operating, investing, and financing activities regarding business acquisitions and the company’s cash flow hedge are contained in notes 4 and 8, respectively. |
We provide you with 20 years of cash flow statements for Nelnet stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Nelnet stock. Explore the full financial landscape of Nelnet stock with our expertly curated income statements.
The information provided in this report about Nelnet stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.